Jiao H, Meng C, Jiao F, Zhou G, Wang L, Wu S
Microorganisms. 2025; 13(2).
PMID: 40005777
PMC: 11858143.
DOI: 10.3390/microorganisms13020412.
Zhuang C, Liu X, Huang X, Lu J, Zhu K, Liao M
Nat Commun. 2025; 16(1):1699.
PMID: 39962038
PMC: 11832733.
DOI: 10.1038/s41467-025-57021-3.
Luo Q, Chen J, Zhang Y, Xu W, Liu Y, Xie C
Liver Res. 2025; 8(1):11-21.
PMID: 39959034
PMC: 11771268.
DOI: 10.1016/j.livres.2024.01.001.
Kogias D, Gavriilidis E, Antoniadou C, Skeva A, Kafalis N, Tsilingiris D
J Viral Hepat. 2025; 32(3):e70005.
PMID: 39927678
PMC: 11809126.
DOI: 10.1111/jvh.70005.
Gan C, Yuan Y, Shen H, Gao J, Kong X, Che Z
Signal Transduct Target Ther. 2025; 10(1):33.
PMID: 39904973
PMC: 11794951.
DOI: 10.1038/s41392-024-02072-z.
Case of Fatal Hepatitis Related to HEV-3 Infection in Central Italy.
Borghi M, Graziani A, Marini D, Madonna E, Villano U, Suffredini E
Viruses. 2025; 16(12.
PMID: 39772179
PMC: 11680277.
DOI: 10.3390/v16121869.
HEV Infection in Beta-Thalassemia Patients.
Papageorgiou D, de Lastic A, Tsachouridou O, Metallidis S, Akinosoglou K
Pathogens. 2025; 13(12.
PMID: 39770318
PMC: 11728467.
DOI: 10.3390/pathogens13121058.
Incidence and risk factors of hepatitis E virus infection in women with gynecological tumors in Eastern China.
Bai W, Wu X, Zhao S, Yu Y, Wang Z, Li X
PeerJ. 2024; 12:e18747.
PMID: 39713139
PMC: 11662898.
DOI: 10.7717/peerj.18747.
One-Pot Assay Based on CRISPR/Cas13a Technology for HEV RNA Point-of-Care Testing.
Fan Z, Xu L, Cao Y, Liu T, Tian Y, Pan Z
J Med Virol. 2024; 96(12):e70115.
PMID: 39704190
PMC: 11660031.
DOI: 10.1002/jmv.70115.
Association of IL1RN VNTR and NKG2A polymorphisms with hepatitis E infection, a case study from western India.
Tripathy A, Wagh P, Shahapure G, Walimbe A, Kadgi N, Nakate L
Arch Virol. 2024; 169(12):250.
PMID: 39560779
DOI: 10.1007/s00705-024-06179-0.
Cost-Effectiveness of Hepatitis E Vaccination Strategies among Patients with Chronic Liver Diseases in China: A Model-Based Evaluation.
Wang F, Zhou L, Wagner A, Chen Z, Lu Y
Vaccines (Basel). 2024; 12(10).
PMID: 39460268
PMC: 11511531.
DOI: 10.3390/vaccines12101101.
Acacetin, a Natural Flavone with Potential in Improving Liver Disease Based on Its Anti-Inflammation, Anti-Cancer, Anti-Infection and Other Effects.
Chen K, Gao Z
Molecules. 2024; 29(20).
PMID: 39459239
PMC: 11509893.
DOI: 10.3390/molecules29204872.
Ritonavir's Evolving Role: A Journey from Antiretroviral Therapy to Broader Medical Applications.
Pereira M, Vale N
Curr Oncol. 2024; 31(10):6032-6049.
PMID: 39451754
PMC: 11505664.
DOI: 10.3390/curroncol31100450.
Viral Hepatitis: Host Immune Interaction, Pathogenesis and New Therapeutic Strategies.
Quirino A, Marascio N, Branda F, Ciccozzi A, Romano C, Locci C
Pathogens. 2024; 13(9).
PMID: 39338957
PMC: 11435051.
DOI: 10.3390/pathogens13090766.
Hepatitis E virus immunosuppressed animal models.
Yadav K, Kenney S
BMC Infect Dis. 2024; 24(1):965.
PMID: 39266958
PMC: 11395946.
DOI: 10.1186/s12879-024-09870-4.
Misdiagnosed Antibiotic-Induced Liver Injury: Unveiling Acute Hepatitis E in a 65-Year-Old Patient.
Muller S, Kaumanns A, Adam K, Osthoff M, Drager S
Am J Case Rep. 2024; 25:e944508.
PMID: 39182163
PMC: 11361320.
DOI: 10.12659/AJCR.944508.
Serological indication of chronic inflammatory demyelinating polyneuropathy as an extrahepatic manifestation of hepatitis E virus infection.
Pischke S, Kjasimov A, Skripuletz T, Casar C, Bannasch J, Mader M
Sci Rep. 2024; 14(1):19244.
PMID: 39164378
PMC: 11336122.
DOI: 10.1038/s41598-024-70104-3.
Systematic Evaluation of Guidelines for the Diagnosis and Treatment of Hepatitis E Virus Infection.
Gu T, Zheng C, Deng Y, Yang X, Bao W, Tang Y
J Clin Transl Hepatol. 2024; 12(8):739-749.
PMID: 39130619
PMC: 11310757.
DOI: 10.14218/JCTH.2023.00508.
Hepatitis E Virus Genotype 3 among Hemodialysis Patients in Mexico: First Identification of Chronic Infection.
Copado-Villagrana E, Duarte-Lopez I, Calderon-Flores A, Loera-Robles I, Viera-Segura O, Fierro N
Pathogens. 2024; 13(7).
PMID: 39057805
PMC: 11280106.
DOI: 10.3390/pathogens13070578.
The Full-Genome Analysis and Generation of an Infectious cDNA Clone of a Genotype 6 Hepatitis E Virus Variant Obtained from a Japanese Wild Boar: In Vitro Cultivation in Human Cell Lines.
Primadharsini P, Takahashi M, Nishizawa T, Sato Y, Nagashima S, Murata K
Viruses. 2024; 16(6).
PMID: 38932135
PMC: 11209168.
DOI: 10.3390/v16060842.